Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 3 Liver Neoplasms 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Lung Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangiopericytoma, Malignant 1 Gallbladder Neoplasms 1 Fibrosarcoma 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Desmoplastic Small Round Cell Tumor 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Bile Duct Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

Trastuzumab 304 Paclitaxel 257 Cyclophosphamide 251 Docetaxel 238 Capecitabine 176 Letrozole 163 Carboplatin 163 Fulvestrant 145 Doxorubicin 145 Bevacizumab 121 Anastrozole 106 Tamoxifen 102 exemestane 94 Vinorelbine 91 Epirubicin 90 pertuzumab 89 Gemcitabine 84 Lapatinib 80 Albumin-Bound Paclitaxel 74 Radiotherapy 71 pembrolizumab 70 palbociclib 64 130-nm albumin-bound paclitaxel 58 eribulin 56 Cisplatin 55 Everolimus 49 pyrotinib 45 Taxes 44 Goserelin 43 Neoadjuvant Therapy 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Breast Neoplasms × exatecan × Clear all

NCT00004046 2012-05-16

Chemotherapy in Treating Women With Metastatic Breast Cancer

Daiichi Sankyo

Phase 2 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡